Loading...

Lansen Pharmaceutical Holdings Limited

0503.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$1.79
HK$0.52(40.94%)

Lansen Pharmaceutical Holdings Limited (0503.HK) Stock Overview

Explore Lansen Pharmaceutical Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.5/100

Key Financials

Market Cap750.6M
P/E Ratio11.16
EPS (TTM)$0.13
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.17

0503.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lansen Pharmaceutical Holdings Limited (0503.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.16 and a market capitalization of 750.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;